Ligelizumab Safely, Effectively Treats Hives

THURSDAY, Oct. 3, 2019 -- Ligelizumab appears to be a safe and effective treatment option for chronic spontaneous urticaria, according to a study published in the Oct. 3 issue of the New England Journal of Medicine.
In a phase 2b dose-finding study,...

Source: Drugs.com - Pharma News - October 3, 2019 Category: Pharmaceuticals Source Type: news